V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215821 | 20179924 | 1.82 | 50 | Curative (C) | 2021-04-07 | 2021-09-29 | CETUXIMAB | 02 | Y | CAPECITABINE + CISPLATIN | 101280153 |
| 20215872 | 20179925 | 1.72 | 66.6 | null | 2021-03-27 | 2021-06-28 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 100252732 |
| 20215878 | 20179926 | 1.64 | null | null | 2020-03-08 | 2020-03-15 | CETUXIMAB | 02 | null | CETUXIMAB | 100226979 |
| 20215943 | 20179928 | 1.82 | 76.7 | Palliative (P) | null | 2019-02-07 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101049715 |
| 20215974 | 20179929 | 1.5 | 92.2 | Palliative (P) | null | 2019-04-03 | Trastuzumab | 02 | null | TRASTUZUMAB | 101771027 |
| 20216024 | 20179930 | 1.73 | 81 | null | 2017-03-19 | 2018-01-04 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 101241366 |
| 20216028 | 20179931 | 1.73 | 64.7 | null | 2017-06-01 | 2018-04-19 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101088180 |
| 20216037 | 20179932 | 1.59 | 81.2 | Curative (C) | 2022-02-07 | 2022-02-14 | Capecitabine + Cisplatin | 2 | N | CAPECITABINE + CISPLATIN | 101352165 |
| 20216041 | 20179933 | 1.77 | 66.3 | null | 2019-07-18 | 2019-08-01 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100510898 |
| 20216067 | 20179935 | 1.8 | 52 | null | 2018-06-25 | 2018-06-26 | CETUXIMAB | 02 | null | CETUXIMAB | 100741522 |
| 20216074 | 20179936 | 1.59 | 75 | Neo-adjuvant (N) | 2020-12-28 | 2021-04-07 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101290405 |
| 20216079 | 20179937 | 1.8 | 69.4 | null | 2020-09-13 | 2020-09-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101582057 |
| 20216094 | 20179938 | 1.73 | 68.9 | null | 2021-02-09 | 2021-02-24 | CETUXIMAB | 2 | null | CETUXIMAB | 101138290 |
| 20216110 | 20179939 | 1.69 | 76.5 | null | 2020-06-15 | 2020-07-06 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100655310 |
| 20216130 | 20179940 | 1.74 | 76.5 | null | 2020-03-12 | 2020-03-26 | Trastuzumab | 02 | null | TRASTUZUMAB | 101029398 |
| 20216173 | 20179941 | 1.7 | 73.5 | 03 | 2019-08-15 | 2019-11-19 | CETUXIMAB | 02 | Y | TRASTUZUMAB | 101823820 |
| 20216208 | 20179942 | 1.55 | 69.6 | Curative (C) | 2017-12-27 | 2018-01-04 | Trastuzumab | 02 | Y | TRASTUZUMAB | 101215533 |
| 20216210 | 20179943 | 1.8 | 56.6 | Palliative (P) | 2022-01-08 | 2022-01-08 | CETUXIMAB | 02 | null | CETUXIMAB | 101660393 |
| 20216213 | 20179944 | 1.62 | 75 | Curative (C) | 2020-11-01 | 2020-11-08 | CETUXIMAB | 02 | null | CETUXIMAB | 101255452 |
| 20216239 | 20179945 | 1.77 | 75 | Curative (C) | 2020-06-20 | 2020-08-11 | CETUXIMAB | 02 | N | CETUXIMAB | 100410098 |
| 20216244 | 20179946 | null | null | Palliative (P) | 2019-06-20 | 2019-06-25 | Trastuzumab | 02 | N | TRASTUZUMAB | 101755791 |
| 20216277 | 20179947 | null | null | null | 2016-07-26 | 2016-08-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 101139226 |
| 20216283 | 20179948 | 1.75 | 94.3 | Curative (C) | 2018-04-18 | 2019-01-19 | CETUXIMAB | 02 | N | CETUXIMAB | 100093604 |
| 20216376 | 20179949 | 1.55 | 82.5 | Curative (C) | 2021-10-29 | 2021-11-06 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101759653 |
| 20216401 | 20179950 | 1.65 | 64 | Palliative (P) | 2020-09-16 | 2021-11-09 | TRASTUZUMAB | 2 | N | TRASTUZUMAB | 100335388 |
| 20216410 | 20179951 | 1.65 | 80.7 | Curative (C) | 2021-10-27 | 2021-11-11 | CETUXIMAB | 02 | N | CETUXIMAB | 101170759 |
| 20216441 | 20179952 | 1.57 | 93 | Adjuvant (A) | 2021-06-06 | 2021-09-22 | Trastuzumab | 02 | null | TRASTUZUMAB | 101643539 |
| 20216461 | 20179953 | 1.63 | 68.1 | Curative (C) | 2018-06-27 | 2018-08-02 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101038626 |
| 20216482 | 20179954 | 1.54 | 44 | null | 2019-11-30 | 2019-12-22 | Cetuximab 14 day | 02 | null | TRASTUZUMAB | 100608251 |
| 20216538 | 20179955 | 1.75 | 62.6 | Palliative (P) | 2015-11-01 | 2017-01-31 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100368325 |
| 20216547 | 20179956 | 1.47 | 41.6 | Palliative (P) | 2019-02-23 | 2019-03-17 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100543523 |
| 20216557 | 20179957 | 1.82 | 82 | null | 2020-09-18 | 2021-04-12 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100582991 |
| 20216621 | 20179958 | 1.82 | 87.6 | Adjuvant (A) | 2021-02-26 | 2021-02-26 | CETUXIMAB | null | Y | CETUXIMAB | 101826216 |
| 20216640 | 20179959 | null | null | Curative (C) | 2017-11-04 | 2017-12-31 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101216275 |
| 20216662 | 20179960 | 1.82 | 73.3 | Palliative (P) | 2020-03-20 | 2020-04-05 | CETUXIMAB | N | N | CETUXIMAB | 101184567 |
| 20216669 | 20179961 | 1.65 | 87.6 | null | 2020-04-28 | 2020-05-26 | CETUXIMAB | 02 | null | CETUXIMAB | 101816080 |
| 20216722 | 20179962 | 1.75 | 100.8 | Palliative (P) | 2018-06-11 | 2018-08-21 | Trastuzumab | 02 | N | TRASTUZUMAB | 100987004 |
| 20216724 | 20179963 | 1.53 | 90.8 | null | 2016-04-14 | 2017-03-26 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 100546967 |
| 20216865 | 20179964 | 1.93 | 81.6 | null | 2017-11-27 | 2017-12-05 | CETUXIMAB | 02 | null | CETUXIMAB | 101333133 |
| 20217106 | 20179965 | 1.72 | null | Palliative (P) | 2019-08-31 | 2019-09-21 | CETUXIMAB | 02 | N | CETUXIMAB | 101305955 |
| 20217211 | 20179966 | 1.62 | 57.7 | null | 2016-07-26 | 2016-10-04 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100599443 |
| 20217333 | 20179967 | 1.77 | 76.6 | Palliative (P) | 2017-11-11 | 2018-03-08 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100638633 |
| 20217455 | 20179969 | 1.76 | 86.1 | Palliative (P) | 2020-09-30 | 2020-10-06 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100146658 |
| 20217485 | 20179970 | 1.65 | null | Neo-adjuvant (N) | null | 2017-12-12 | CETUXIMAB | 99 | N | CETUXIMAB | 100024653 |
| 20217655 | 20179972 | 1.76 | 181.5 | null | 2021-12-08 | 2022-01-05 | Trastuzumab | 02 | null | TRASTUZUMAB | 101732104 |
| 20217724 | 20179973 | 1.65 | null | Adjuvant (A) | 2020-04-28 | 2020-05-26 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100290850 |
| 20217781 | 20179974 | 1.65 | null | Palliative (P) | 2019-06-05 | 2019-06-15 | CETUXIMAB | 02 | N | CETUXIMAB | 100499828 |
| 20217934 | 20179975 | 1.62 | 85 | null | 2016-03-06 | 2016-09-14 | Trastuzumab | 02 | null | TRASTUZUMAB | 101174738 |
| 20217989 | 20179976 | 1.65 | 50 | Palliative (P) | 2018-01-25 | 2018-01-25 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101038346 |
| 20217992 | 20179977 | 1.62 | 59.5 | null | 2019-07-16 | 2019-07-18 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 101860127 |